{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:40:57Z","timestamp":1786736457249,"version":"build-2736575974"},"reference-count":125,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Res Pharma Sci"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/1735-5362.272534","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T05:13:00Z","timestamp":1575868380000},"page":"471","source":"Crossref","is-referenced-by-count":24,"title":["Receptor targeting drug delivery strategies and prospects in the treatment of rheumatoid arthritis"],"prefix":"10.4103","volume":"14","author":[{"given":"Jaber","family":"Emami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Ansarypour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1735-5362.272534-1","first-page":"269","article-title":"The epidemiology of rheumatoid arthritis.Rheum Dis Clin North Am","author":"Gabriel","year":"2001","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-2","unstructured":"Fauci AS, Langford C. Harrison\u2019s Rheumatology. 3rd ed. New York: McGraw-Hill Education; 2013. pp. 87-106."},{"key":"key-10.4103\/1735-5362.272534-3","unstructured":"Shah A, Clair EW. Rheumatoid Arthritis. In: Jameson JL, Fauci A, Kasper D, Hauser S, Longo D, Loscalzo J. Harrison\u2019s Principles of Internal Medicine. 20th ed. New York: McGraw Hill Professional; 2018. pp. 2527-2541."},{"key":"key-10.4103\/1735-5362.272534-4","first-page":"2055","article-title":"Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis.Arthritis Rheum","author":"Ballara","year":"2001","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-5","first-page":"4339","article-title":"Weibel- Palade bodies as a marker for neovascularization induced by tumor and rheumatoid angiogenesis factors.Cancer Res","author":"Kumar","year":"1985","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-6","first-page":"237","article-title":"Rheumatoid arthritis and osteoarthritis synovial fluid effects on primary human endothelial cell cultures.J Rheumatol","author":"Semble","year":"1985","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-7","first-page":"473","article-title":"Therapeutic strategies for rheumatoid arthritis.Nat Rev Drug Discov","author":"Smolen","year":"2003","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-8","first-page":"845","article-title":"Drug delivery targets and systems for targeted treatment of rheumatoid arthritis.J Drug Target","author":"Feng","year":"2018","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-9","first-page":"953","article-title":"Clinical significance of Janus kinase inhibitor selectivity.Rheumatology (Oxford)","author":"Choy","year":"2019","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-10","first-page":"1205","article-title":"Development of macromolecular prodrug for rheumatoid arthritis.Adv Drug Deliv Rev","author":"Yuan","year":"2012","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-11","first-page":"137","article-title":"Adhesion molecule expression in human synovial tissue.Arthritis Rheum","author":"Johnson","year":"1993","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-12","first-page":"ii96","article-title":"Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases.Ann Rheum Dis","author":"Wilder","year":"2002","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-13","first-page":"2666","article-title":"Effectiveness of anti-folate receptor beta antibody conjugated with truncated Pseudomonas exotoxin in the targeting of rheumatoid arthritis synovial macrophages.Arthritis Rheum","author":"Nagayoshi","year":"2005","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-14","first-page":"12","article-title":"Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients.Arthritis Rheum","author":"van","year":"2009","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-15","first-page":"53","article-title":"Scintigraphy using a technetium 99m-labelled anti-E-selectin Fab fragment in rheumatoid arthritis.Rheumatology (Oxford)","author":"Jamar","year":"2002","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-16","first-page":"1442","article-title":"The folate receptor works in tandem with a probenecid-sensitive carrier in MA104 cells in vitro.J Clin Invest","author":"Kamen","year":"1991","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-17","first-page":"2807","article-title":"The biological chemistry of folate receptors.Blood","author":"Antony","year":"1992","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-18","doi-asserted-by":"crossref","unstructured":"Ross JF, Chaudhuri PK, Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer. 1994;73(9):2432-2443.","DOI":"10.1002\/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S"},{"key":"key-10.4103\/1735-5362.272534-19","first-page":"1609","article-title":"Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis.Arthritis Rheum","author":"Nakashima-Matsushita","year":"1999","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-20","first-page":"189","article-title":"Macrophages in rheumatoid arthritis.Arthritis Res","author":"Kinne","year":"2000","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-21","first-page":"504","article-title":"The development of folate-PAMAM dendrimer conjugates for targeted delivery of anti-arthritic drugs and their pharmacokinetics and biodistribution in arthritic rats.Biomaterials","author":"Chandrasekar","year":"2007","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-22","first-page":"92","article-title":"Folate coupled poly(ethyleneglycol) conjugates of anionic poly(amidoamine) dendrimer for inflammatory tissue specific drug delivery.J Biomed Mater Res A","author":"Chandrasekar","year":"2007","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-23","first-page":"2671","article-title":"Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis.Arthritis Rheum","author":"Thomas","year":"2011","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-24","first-page":"2060","article-title":"Characterization of folate-chitosan-DNA nanoparticles for gene therapy.Biomaterials","author":"Mansouri","year":"2006","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-25","doi-asserted-by":"crossref","unstructured":"Hattori Y, Sakaguchi M, Maitani Y. Folate-linked lipid-based nanoparticles deliver a NFkappaB decoy into activated murine macrophage-like RAW264.7 cells. Biol Pharm Bull. 2006;29(7):1516-1520.","DOI":"10.1248\/bpb.29.1516"},{"key":"key-10.4103\/1735-5362.272534-26","first-page":"58","article-title":"Combination of NF-kB targeted siRNA and methotrexate in a hybrid nanocarrier towards the effective treatment in rheumatoid arthritis.J Nanobiotechnol","author":"Duan","year":"2018","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-27","first-page":"1","article-title":"Delivery of siRNA using folate receptor- targeted pH-sensitive polymeric nanoparticles for rheumatoid arthritis therapy.Nanomed Nanotechnol","author":"Sun","year":"2019","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-28","first-page":"39","article-title":"Dual-functional lipid polymeric hybrid pH-responsive nanoparticles decorated with cell penetrating peptide and folate for therapy against rheumatoid arthritis.Eur J Pharm Biopharm","author":"Zhao","year":"2018","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-29","first-page":"1182","article-title":"Folate receptor-targeted mixed polysialic acid micelles for combating rheumatoid arthritis: in vitro and in vivo evaluation.Drug Deliv","author":"Zhang","year":"2018","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-30","first-page":"123","article-title":"Folate conjugated double liposomes bearing prednisolone and methotrexate for targeting rheumatoid arthritis.Pharm Res","author":"Verma","year":"2019","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-31","first-page":"12","article-title":"Adhesion molecules and homing in inflamed synovial.Immun Infekt","author":"Fischer","year":"1993","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-32","doi-asserted-by":"crossref","unstructured":"Haynes BF, Hale LP, Patton KL, Martin ME, McCallum RM. Measurement of an adhesion molecule as an indicator of inflammatory disease activity. Up-regulation of the receptor for hyaluronate (CD44) in rheumatoid arthritis. Arthritis Rheum. 1991;34(11):1434-1443.","DOI":"10.1002\/art.1780341115"},{"key":"key-10.4103\/1735-5362.272534-33","first-page":"105","article-title":"CD44 in rheumatoid arthritis.Arthritis Res Ther","author":"Naor","year":"2003","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-34","first-page":"295","article-title":"Hyaluronan nanoparticles bearing gamma-secretase inhibitor: in vivo therapeutic effects on rheumatoid arthritis.J Control Release","author":"Heo","year":"2014","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-35","first-page":"E146","article-title":"Hyaluronic acid coated acid-sensitive nanoparticles for targeted therapy of adjuvant-induced arthritis in rats.Molecules","author":"Yu","year":"2019","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-36","first-page":"716","article-title":"Targeted delivery of hyaluronic acid-coated solid lipid nanoparticles for rheumatoid arthritis therapy.Drug Deliv","author":"Zhou","year":"2018","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-37","first-page":"4790","article-title":"Hyaluronate-gold nanoparticle\/tocilizumab complex for the treatment of rheumatoid arthritis.ACS Nano","author":"Lee","year":"2014","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-38","first-page":"7632","article-title":"A hyaluronic acid-methotrexate conjugate for targeted therapy of rheumatoid arthritis.Chem Commun (Camb)","author":"Shin","year":"2014","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-39","first-page":"9057","article-title":"Ionic complex systems based on hyaluronic acid and PEGylated TNF-related apoptosis-inducing ligand for treatment of rheumatoid arthritis.Biomaterials","author":"Kim","year":"2010","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-40","first-page":"79","article-title":"Novel hyaluronic acid-methotrexate conjugate suppresses joint inflammation in the rat knee: efficacy and safety evaluation in two rat arthritis models.Arthritis Res Ther","author":"Tamura","year":"2016","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-41","first-page":"11849","article-title":"pH-Responsive hyaluronic acid-based nanocarrier for treatment of rheumatoid arthritis.J Nanosci Nanotechnol","author":"Jeon","year":"2016","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-42","first-page":"24984","article-title":"Injectable click-crosslinked hyaluronic acid depot to prolong therapeutic activity in articular joints affected by rheumatoid arthritis.ACS Appl Mater Interfaces","author":"Seo","year":"2019","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-43","first-page":"403","article-title":"Thermo-sensitive injectable hydrogel based on the physical mixing of hyaluronic acid and Pluronic F-127 for sustained NSAID delivery.Carbohyd Polym","author":"Jung","year":"2017","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-44","first-page":"1037","article-title":"Hyaluronic acid-conjugated pH-sensitive liposomes for targeted delivery of prednisolone on rheumatoid arthritis therapy.Nanomedicine (Lond)","author":"Gouveia","year":"2018","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-45","first-page":"143","article-title":"Integrin alpha v beta 3 antagonists for anti-angiogenic cancer treatment.Recent Pat Anticancer Drug Discov","author":"Hsu","year":"2007","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-46","first-page":"569","article-title":"Requirement of vascular integrin alpha v beta 3 for angiogenesis.Science","author":"Brooks","year":"1994","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-47","first-page":"81","article-title":"Integrin activation is required for VEGF and FGF receptor protein presence on human microvascular endothelial cells.Mol Cell Biochem","author":"Tsou","year":"2001","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-48","first-page":"2284","article-title":"Immunohistochemical analysis of vascular endothelial growth factor expression in severe and destructive rheumatoid arthritis.J Rheumatol","author":"Weber","year":"2000","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-49","first-page":"4853","article-title":"Blockade of vascular endothelial growth factor receptor I (VEGF-RI), but not VEGF-RII, suppresses joint destruction in the K\/BxN model of rheumatoid arthritis.J Immunol","author":"De","year":"2003","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-50","first-page":"434","article-title":"Angiogenesis inhibition as a therapeutic approach for inflammatory synovitis.Nat Clin Pract Rheumatol","author":"Lainer-Carr","year":"2007","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-51","first-page":"4556","article-title":"Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice.Proc Natl Acad Sci USA","author":"Yumoto","year":"2002","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-52","first-page":"1669","article-title":"Functionalized STAT1 siRNA nanoparticles regress rheumatoid arthritis in a mouse model.Nanomedicine (Lond)","author":"Scheinman","year":"2011","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-53","first-page":"50","article-title":"Targeted chemo-photothermal treatments of rheumatoid arthritis using gold half-shell multifunctional nanoparticles.ACS Nano","author":"Lee","year":"2013","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-54","first-page":"1198","article-title":"Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis.Arthritis Rheum","author":"Koning","year":"2006","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-55","first-page":"708","article-title":"Enhanced therapeutic effect of RGD-modified polymeric micelles loaded with low-dose methotrexate and nimesulide on Rheumatoid Arthritis.Theranostics","author":"Wang","year":"2019","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-56","first-page":"455","article-title":"Expression of E-selectin on endothelial cells of small veins in human colorectal cancer.Int J Cancer","author":"Ye","year":"1995","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-57","first-page":"249","article-title":"Expression of endothelial cell adhesion molecules in neovascularized tissue.Microcirculation","author":"Vallien","year":"2000","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-58","first-page":"6387","article-title":"E-selectin up-regulation allows for targeted drug delivery in prostate cancer.Cancer Res","author":"Bhaskar","year":"2003","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-59","first-page":"527","article-title":"Selectins-an emerging target for drug delivery.Adv Drug Deliv Rev","author":"Ehrhardt","year":"2004","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-60","first-page":"122","article-title":"The discovery, biology, and drug development of sialyl Lea and sialyl Lex.Arch Biochem Biophys","author":"Magnani","year":"2004","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-61","first-page":"833","article-title":"Selectin-carbohydrate interactions: from natural ligands to designed mimics.Chem Rev","author":"Simanek","year":"1998","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-62","first-page":"566","article-title":"Design and synthesis of sialyl Lewis(x) mimics as E- and P-selectin inhibitors.Med Res Rev","author":"Kaila","year":"2002","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-63","first-page":"64","article-title":"In vitro cellular handling and in vivo targeting of E-selectin-directed immunoconjugates and immunoliposomes used for drug delivery to inflamed endothelium.Pharm Res","author":"Everts","year":"2003","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-64","first-page":"1887","article-title":"Designing micro- and nano-particles for treating rheumatoid arthritis.Arch Pharm Res","author":"Mitragotri","year":"2011","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-65","first-page":"553","article-title":"Accumulation of liposome with Sialyl Lewis X to inflammation and tumor region: application to in vivo bio-imaging.Biochem Biophys Res Commun","author":"Hirai","year":"2007","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-66","first-page":"719","article-title":"Recent progress in the development of toll-like receptor (TLR) antagonists.Expert Opin Ther Pat","author":"Patra","year":"2016","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-67","first-page":"243","article-title":"Toll-like receptors and NOD-like receptors in rheumatic diseases.Arthritis Res Ther","author":"McCormack","year":"2009","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-68","first-page":"2012","article-title":"Mechanisms of immune complex-mediated neutrophil recruitment and tissue injury.Circulation","author":"Mayadas","year":"2009","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-69","first-page":"34","article-title":"Fcgamma receptors as regulators of immune responses.Nat Rev Immunol","author":"Nimmerjahn","year":"2008","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-70","first-page":"S265","article-title":"Epidemiology and genetics of rheumatoid arthritis.Arthritis Res","author":"Silman","year":"2002","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-71","first-page":"2478","article-title":"The toll-like receptor-nuclear factor kappaB pathway in rheumatoid arthritis.Front Biosci","author":"Andreakos","year":"2005","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-72","first-page":"304","article-title":"Toll receptors in innate immunity.Trends Cell Biol","author":"Imler","year":"2001","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-73","first-page":"335","article-title":"Toll-like receptors.Annu Rev Immuno","author":"Takeda","year":"2003","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-74","first-page":"6012","article-title":"Reverse transcriptase-PCR analysis of bacterial rRNA for detection and characterization of bacterial species in arthritis synovial tissue.Infect Immun","author":"Kempsell","year":"2000","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-75","first-page":"593","article-title":"Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides.Arthritis Rheum","author":"van","year":"2000","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-76","first-page":"2313","article-title":"The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7\/8 results in synergistic cytokine production by dendritic cells.Arthritis Rheum","author":"Roelofs","year":"2005","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-77","first-page":"1457","article-title":"Expression of toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.Arthritis Rheum","author":"Iwahashi","year":"2004","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-78","first-page":"1435","article-title":"Activation of Toll-like receptor 2 by a novel preparation of cell wall skeleton from Mycobacterium bovis BCG Tokyo (SMP-105) sufficiently enhances immune responses against tumors.Cancer Sci","author":"Murata","year":"2008","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-79","first-page":"R33","article-title":"Blockade of Toll-like receptor 2 prevents spontaneous cytokine release from rheumatoid arthritis ex vivo synovial explant cultures.Arthritis Res Ther","author":"Ultaigh","year":"2011","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-80","first-page":"103","article-title":"TLRs, future potential therapeutic targets for RA.Autoimmun Rev","author":"Elshabrawy","year":"2017","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-81","first-page":"1395","article-title":"Toll-like receptors: potential targets for lupus treatment.Acta Pharmacol Sin","author":"Wu","year":"2015","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-82","first-page":"1","article-title":"Emerging role of endosomal toll-like receptors in rheumatoid arthritis.Front Immunol","author":"Thwaites","year":"2014","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-83","first-page":"5998","article-title":"Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells.J Immunol","author":"Muzio","year":"2000","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-84","first-page":"2656","article-title":"RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3.Arthritis Rheum","author":"Brentano","year":"2005","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-85","first-page":"369","article-title":"Antimicrobial peptides are expressed and produced in healthy and inflamed human synovial membranes.J Pathol","author":"Paulsen","year":"2002","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-86","first-page":"e26632","article-title":"LL37 and cationic peptides enhance TLR3 signaling by viral double-stranded RNAs.PLoS One","author":"Lai","year":"2011","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-87","first-page":"928","article-title":"Hypoxia and hypoxia-inducible factor-1a provoke toll-like receptor signalling-induced inflammation in rheumatoid arthritis.Ann Rheum Dis","author":"Hu","year":"2014","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-88","first-page":"429","article-title":"Engagement of toll-like receptor 3 induces vascular endothelial growth factor and interleukin-8 in human rheumatoid synovial fibroblasts.Korean J Intern Med","author":"Moon","year":"2010","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-89","first-page":"R103","article-title":"Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats.Arthritis Res Ther","author":"Meng","year":"2010","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-90","first-page":"263","article-title":"Overexpression of toll-like receptor 3 in spleen is associated with experimental arthritis in rats.Scand J Immunol","author":"Zhu","year":"2012","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-91","first-page":"177","article-title":"Therapeutic targeting of toll-like receptors for infectious and inflammatory diseases and cancer.Pharmacol Rev","author":"O\u2019Neill","year":"2009","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-92","first-page":"7021","article-title":"Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis.J Immunol","author":"Roelofs","year":"2006","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-93","first-page":"774","article-title":"Tenascin-C is an endogenous activator of toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease.Nat Med","author":"Midwood","year":"2009","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-94","first-page":"e23539","article-title":"Toll-like receptor 4 is involved in inflammatory and joint destructive pathways in collagen-induced arthritis in DBA1J mice.PLoS One","author":"Pierer","year":"2011","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-95","first-page":"204","article-title":"Molecular size hyaluronan differently modulates toll-like receptor-4 in LPS-induced inflammation in mouse chondrocytes.Biochimie","author":"Campo","year":"2010","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-96","first-page":"1852","article-title":"The inhibition of hyaluronan degradation reduced pro-inflammatory cytokines in mouse synovial fibroblasts subjected to collagen-induced arthritis.J Cell Biochem","author":"Campo","year":"2012","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-97","first-page":"2373","article-title":"Hyaluronan fragments activate an NF-kappa B\/I-kappa B alpha autoregulatory loop in murine macrophages.J Exp Med","author":"Noble","year":"1996","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-98","first-page":"1863","article-title":"Oligosaccharides of hyaluronan are potent activators of dendritic cells.J Immunol","author":"Termeer","year":"2000","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-99","first-page":"69","article-title":"Hyaluronan differently modulates TLR-4 and the inflammatory response in mouse chondrocytes.Biofactors","author":"Campo","year":"2012","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-100","first-page":"1046","article-title":"AB0451 NI-0101, a monoclonal antibody targeting toll like receptor 4 (TLR4) being developed for rheumatoid arthritis (RA) treatment with a potential for personalized medicine.Ann Rheum Dis","author":"Monnet","year":"2015","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-101","first-page":"49","article-title":"TLR4\/MD2 specific peptides stalled in vivo LPS-induced immune exacerbation.Biomaterials","author":"Park","year":"2017","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-102","first-page":"295","article-title":"Suppression of experimental arthritis with self-assembling glycol-split heparin nanoparticles via inhibition of TLR4-NF-kappaB signaling.J Control Release","author":"Babazada","year":"2014","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-103","first-page":"4486","article-title":"Bergenin loaded gum xanthan stabilized silver nanoparticles suppress synovial inflammation through modulation of the immune response and oxidative stress in adjuvant induced arthritic rats.J Mater Chem B","author":"Rao","year":"2018","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-104","first-page":"1","article-title":"Opuntioside, opuntiol and its metallic nanoparticles attenuate adjuvant-induced arthritis: novel suppressors of toll-like receptors -2 and -4.Biomed Pharmacother","author":"Roome","year":"2019","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-105","first-page":"475","article-title":"TLR5, a novel and unidentified inflammatory mediator in rheumatoid arthritis that correlates with disease activity score and joint TNF-\u03b1 levels.J Immunol","author":"Chamberlain","year":"2012","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-106","first-page":"R142","article-title":"Investigation of the role of endosomal toll-like receptors in murine collagen-induced arthritis reveals a potential role for TLR7 in disease maintenance.Arthritis Res Ther","author":"Alzabin","year":"2012","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-107","first-page":"3649","article-title":"Effector T cells in rheumatoid arthritis: lessons from animal models.FEBS Lett","author":"Alzabin","year":"2011","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-108","first-page":"2764","article-title":"Prevention of autoimmune disease by induction of tolerance to Toll-like receptor 7.Proc Natl Acad Sci USA","author":"Hayashi","year":"2009","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-109","first-page":"3651","article-title":"TLR8 deficiency leads to autoimmunity in mice.J Clin Invest","author":"Demaria","year":"2010","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-110","first-page":"919","article-title":"DNA binding to proteolytically activated TLR9 is sequence- independent and enhanced by DNA curvature.EMBO J","author":"Li","year":"2012","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-111","first-page":"837","article-title":"Activation of autoreactive B cells by CpG dsDNA.Immunity","author":"Viglianti","year":"2003","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-112","first-page":"4399","article-title":"The involvement of Toll-like receptor 9 in the pathogenesis of erosive autoimmune arthritis.J Cell Mol Med","author":"Fischer","year":"2018","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-113","first-page":"1","article-title":"Hydroxychloroquine efficiently suppresses inflammatory responses of human class-switched memory B cells via Toll-like receptor 9 inhibition.Clin Immunol","author":"Torigoe","year":"2018","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-114","first-page":"683","article-title":"Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors.Arthritis Rheum","author":"Sacre","year":"2010","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-115","first-page":"3947","article-title":"Design, synthesis and biological evaluation of novel antagonist compounds of toll-like receptors 7, 8 and 9.Nucleic Acids Res","author":"Kandimalla","year":"2013","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-116","first-page":"68","article-title":"Size-dependent attenuation of TLR9 signaling by gold nanoparticles in macrophages.J Immunol","author":"Tsai","year":"2012","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-117","first-page":"4298","article-title":"Tuned cationic dendronized polymer: molecular scavenger for rheumatoid arthritis treatment.Angew Chem","author":"Peng","year":"2019","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-118","first-page":"242","article-title":"Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.Semin Immunol","author":"Fukata","year":"2009","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-119","first-page":"231","article-title":"NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis.Clin Exp Immunol","author":"Guo","year":"2018","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-120","first-page":"153","article-title":"Quercetin attenuates collagen-induced arthritis by restoration of Th17\/Treg balance and activation of heme oxygenase 1-mediated anti-inflammatory effect.Int Immunopharmacol","author":"Yang","year":"2018","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-121","first-page":"228","article-title":"Humanised effector-null Fc\u03b3RIIA antibody inhibits immune complex-mediated proinflammatory responses.Ann Rheum Dis","author":"Chen","year":"2019","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-122","first-page":"34","article-title":"Primer: inflammasomes and interleukin 1beta in inflammatory disorders.Nat Clin Pract Rheumatol","author":"Church","year":"2008","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-123","first-page":"433","article-title":"Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of toll-like receptor signaling.Immunity","author":"Kanneganti","year":"2007","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-124","first-page":"a001651,1","article-title":"The nuclear factor NF-kappaB pathway in inflammation.Cold Spring Harb Perspect Biol","author":"Lawrence","year":"2009","journal-title":""},{"key":"key-10.4103\/1735-5362.272534-125","first-page":"311","article-title":"Cross-talk between pathogen recognizing Toll-like receptors and immunoglobulin Fc receptors in immunity.Immunol Rev","author":"van","year":"2015","journal-title":""}],"container-title":["Research in Pharmaceutical Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:42:04Z","timestamp":1786732924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1735-5362.272534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":125,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"alternative-id":["272534"],"URL":"https:\/\/doi.org\/10.4103\/1735-5362.272534","relation":{},"ISSN":["1735-5362"],"issn-type":[{"value":"1735-5362","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}